Review article · 2023 · Open access

Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery

Naina Sunildutt, Pratibha Parihar, Abdul Rahim Chethikkattuveli Salih, Sang Ho Lee, Kyung Hyun Choi

Frontiers in Pharmacology, 14, 1139229 · Published 25 April 2023 · DOI 10.3389/fphar.2023.1139229

Open PDFView at the publisherCite this paper

In brief

“Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery” is a 2023 review article by Naina Sunildutt and 4 co-authors, published in Frontiers in Pharmacology. OpenAlex counts 71 citations as of 19 November 2026, which puts it in the top 2% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Pharmacology.

Citations
71
Most cited in
2024 (25)
Field-weighted impact
1.39
References
197
Authors
5

Abstract

The inefficiency of existing animal models to precisely predict human pharmacological effects is the root reason for drug development failure. Microphysiological system/organ-on-a-chip technology (organ-on-a-chip platform) is a microfluidic device cultured with human living cells under specific organ shear stress which can faithfully replicate human organ-body level pathophysiology. This emerging organ-on-chip platform can be a remarkable alternative for animal models with a broad range of purposes in drug testing and precision medicine. Here, we review the parameters employed in using organ on chip platform as a plot mimic diseases, genetic disorders, drug toxicity effects in different organs, biomarker identification, and drug discoveries. Additionally, we address the current challenges of the organ-on-chip platform that should be overcome to be accepted by drug regulatory agencies and pharmaceutical industries. Moreover, we highlight the future direction of the organ-on-chip platform parameters for enhancing and accelerating drug discoveries and personalized medicine.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sunildutt, N., Parihar, P., Salih, A. R. C., Lee, S. H., & Choi, K. H. (2023). Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery. Frontiers in Pharmacology, 14, 1139229. https://doi.org/10.3389/fphar.2023.1139229

MLA 9

Sunildutt, Naina, et al. “Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery.” Frontiers in Pharmacology, vol. 14, 2023, p. 1139229. https://doi.org/10.3389/fphar.2023.1139229.

Chicago

Sunildutt, Naina, Pratibha Parihar, Abdul Rahim Chethikkattuveli Salih, Sang Ho Lee, and Kyung Hyun Choi. 2023. “Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery.” Frontiers in Pharmacology 14: 1139229. https://doi.org/10.3389/fphar.2023.1139229.

Harvard

Sunildutt, N. et al. (2023) ‘Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery’, Frontiers in Pharmacology, 14, p. 1139229. doi:10.3389/fphar.2023.1139229.

IEEE

N. Sunildutt, P. Parihar, A. R. C. Salih, S. H. Lee, and K. H. Choi, “Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery,” Frontiers in Pharmacology, vol. 14, p. 1139229, 2023, doi: 10.3389/fphar.2023.1139229.

BibTeX

@article{sunildutt2023revolutionizing,
  title     = {{Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery}},
  author    = {Sunildutt, Naina and Parihar, Pratibha and Salih, Abdul Rahim Chethikkattuveli and Lee, Sang Ho and Choi, Kyung Hyun},
  journal   = {Frontiers in Pharmacology},
  year      = {2023},
  volume    = {14},
  pages     = {1139229},
  doi       = {10.3389/fphar.2023.1139229},
  url       = {https://doi.org/10.3389/fphar.2023.1139229}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202366
20242525
20252121
20261919

Its field-weighted citation impact is 1.39: it has been cited 1.39 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research

  • organ-on-a-chip
  • microphysiological systems
  • disease modeling
  • drug discovery
  • drug toxicity
  • biomarker discovery
  • alternative to animal models
  • precision medicine

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Sunildutt, N., Parihar, P., Salih, A. R. C., Lee, S. H., & Choi, K. H. (2023). Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery. Frontiers in Pharmacology, 14, 1139229. https://doi.org/10.3389/fphar.2023.1139229

How many times has this paper been cited?

71 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Pharmacology: sign in and open the PDF from this page.

Who wrote this paper?

Naina Sunildutt, Pratibha Parihar, Abdul Rahim Chethikkattuveli Salih, Sang Ho Lee, Kyung Hyun Choi.

What is the DOI of this paper?

10.3389/fphar.2023.1139229, permanently at https://doi.org/10.3389/fphar.2023.1139229. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.